ApoJ/Clusterin Peptide as a Novel Therapeutic Agent for

Project: Research project

Description

ApoJ/Clusterin Peptide as a Novel Therapeutic Agent for Alzheimer's Disease
StatusFinished
Effective start/end date10/15/136/30/16

Funding

  • Alzheimer's Drug Discovery Foundation

Fingerprint

Clusterin
Alzheimer Disease
Peptides
Therapeutics